Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease - Jernberg, T; Payne, CD; Winters, KJ (Eur Heart J, 2006)
et al.